Impurity Profiling Using Convergence Chromatography and Mass Spectrometry

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-07-15-2013
Volume 2013 eBook
Issue 1

The authors describe the use of convergence chromatography combined with mass spectrometry for impurity profiling.

 

Coupling ultra-performance convergence chromatography to mass spectrometry provides an important tool for pharmaceutical analysis.

The authors describe the use of convergence chromatography combined with mass spectrometry for impurity profiling. This was achieved by using metoclopramide and its related substances and metoclopramide drug products as examples.

View 

Pharmaceutical Technology’s 2013 Analytical and Bioanalytical Testing ebook

.

 

 

 

Articles in this issue
pt-ebook_chrom.jpg
Impurity Profiling Using Convergence Chromatography and Mass Spectrometry
pt_ebooks_nmr.jpg
Multiple Reaction Monitoring–Mass Spectrometry for Biopharmaceutical Analysis
pt_ebooks_lcms.jpg
Simultaneous Quantitative and Qualitative Measurements in Drug-Metabolism Investigations
pt_ebooks_protein.jpg
Identification and Quantification of Trace-Level Protein Impurities
pt_ebooks_hplc.jpg
Ultra-High-Speed Analysis of Ibuprofen Using HPLC
pt_ebooks_microscopy.jpg
Characterization with Atomic Force Microscopy, Topographic, and 3D Raman
Recent Videos
Lee Cronin, founder and CEO of Chemify
Related Content
A magnifying glass examining a vintage vaccine vial surrounded by four minimalistic chart icons, symbolizing healthcare, medicine, and analytics in the context of global health monitoring. | Image source: ©huiying - stock.adobe.com

ICH Q6B for Analytics

Richard Easton;Christopher Ziegenfuss
June 6th 2025
Article

ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Unidentified microbiologist is place the petri dish and tubes into incubator to incubate the culture of bacteria or fungi growth in appropriate condition, concept of microbial laboratory. | Image Credit: © Sukjai Photo – © Sukjai Photo – Stock.Adobe.com

Evolving Cleanroom Procedures and Sterility Challenges

Feliza Mirasol
May 6th 2025
Article

The shift toward personalized medicines poses new challenges in cleanroom protocols.

Macro view on vials | Image Credit: © yuriygolub - stock.adobe.com

Extractable and Leachable Challenges in Lyophilized Drug Products

Alan Xu;Piet Christiaens
April 5th 2025
Article

The authors examine the risks of extractables and leachables, and present solutions that emphasize the importance of a strategic, multi-prong approach.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Beckman Coulter Life Sciences Launches Modular Spectral Flow Cytometry Module, First of Its Kind in Industry

Feliza Mirasol
March 28th 2025
Article

The CytoFLEX mosaic Spectral Detection Module offers up to 88 channels for detection.

research, doctor, microscope, experiment, dx, digital transformation, data, analysis, science, researcher, graph, chart, pharmaceutical, pharmacy, medicine, information, development, research institute | Image Credit: ©metamorworks - stock.adobe.com

Full Tolerance Coverage Method for Assessing Uniformity of Dosage Units with Large Sample Sizes

Pramote Cholayudth
March 10th 2025
Article

The ‘full tolerance coverage method’ is introduced as a coverage estimation approach for assessing the uniformity of dosage units from large sample sizes, ensuring that no dosage unit exceeds the specification range.